Another weight-loss pill in the works, as Ozempic-maker Novo Nordisk strikes deal with Boston startup

Vivtex, cofounded by renowned MIT professor Robert Langer, stands to make as much as $2.1 billion if milestones are met.

Could Novo Nordisk Help Turn $100,000 Into $1 Million in the GLP‑1 Gold Rush?

It would be a near-miracle gain.

Analyst says he’s thrown in the towel on Novo Nordisk after latest setback

Novo Nordisk’s study showing a new drug wasn’t as good as a rival’s led one sell-side analyst to downgrade the stock for the ...

Novo Nordisk’s New Weight‑Loss Drug Just Failed a Big Trial—So Why Is It Still Headed to Market?

The Danish drugmaker’s latest trial setback intensifies its high-stakes rivalry with Eli Lilly in the booming obesity market.
PharmExec

Pharma Mergers and Acquisitions Roundup: Novo Nordisk Enters $2.1 Billion Partnership with Vivtex, GSK Enters $950 Million Acquisition Agreement with 35Pharma Inc.

Novo Nordisk partners with Vivtex Corporation to develop next-generation oral biologics for obesity and diabetes, while GSK agrees to acquire 35Pharma Inc. to expand its pulmonary hypertension ...

Novo Nordisk Foundation backs quantum computing and life sciences beyond Denmark

Novo Nordisk Foundation, the world’s richest philanthropic organisation, is boosting spending beyond its home of Denmark to bolster Europe’s capabilities in fields including quantum computing and life ...

Novo Nordisk trial ‘own goal’ sparks flurry of analyst downgrades

Analysts raced to cut price targets on an already struggeling Novo Nordisk stock following disappointing trial results for ...

These stocks are today’s movers: AMD, Home Depot, Novo Nordisk, Hims & Hers, Keysight, Vir Biotechnology, and more

Advanced Micro Devices rallies after the chip maker unveils a multi-year deal to supply computing power to Meta Platforms, ...